Raleigh Capital Management »

Cytomx Therapeutics shares owned by Raleigh Capital Management

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Raleigh Capital Management from 13F filings

Historical chart of Raleigh Capital Management investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Raleigh Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Raleigh Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $388 250 1.55
2023-09-30 $323 250 1.29
2023-06-30 $430 250 1.72
2023-03-31 $378 250 1.51
2022-12-31 $400 250 1.60
2022-09-30 $0 250 0.00
2022-06-30 $0 250 0.00
2022-03-31 $1.0k 250 4.00